ORINF (Orion Oyj) ROCE %: 33.38% (As of Mar. 2026)


ORINF Orion Oyj ORINF
100 GF Score
Price $82.75
GF Value $86.78
! 2 Warning Signs
View Full Analysis

What is Orion Oyj ROCE %?

Orion Oyj ORINF +4.81% 100 ROCE % is 33.38% as of Mar. 2026. GuruFocus rates ORINF with a GF Score™ of 100/100 and a GF Value™ of $86.78. The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Orion Oyj's annualized ROCE % for the quarter that ended in Mar. 2026 was 33.38%.

Orion Oyj  (OTCPK:ORINF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Orion Oyj ROCE % Related Terms

Orion Oyj ROCE % Historical Data

* Premium members only.

The historical data trend for Orion Oyj's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Orion Oyj ROCE % Chart

Orion Oyj Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.95 40.29 23.41 32.64 47.79

Orion Oyj Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.74 34.33 42.39 99.06 33.38
ORINF
100GF Score
Orion Oyj ORINF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Orion Oyj ROCE % Calculation

Orion Oyj's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=744.731/( ( (1705.864 - 286.597) + (2353.396 - 656.089) )/ 2 )
=744.731/( (1419.267+1697.307)/ 2 )
=744.731/1558.287
=47.79 %

Orion Oyj's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=530.404/( ( (2353.396 - 656.089) + (2403.584 - 923.237) )/ 2 )
=530.404/( ( 1697.307 + 1480.347 )/ 2 )
=530.404/1588.827
=33.38 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 33.38% mean?
Orion Oyj (ORINF) has a ROCE % of 33.38% as of Mar. 2026.
Is Orion Oyj's ROCE % too high?
Orion Oyj's current ROCE % is 33.38%. The Drug Manufacturers industry median ROCE % is 7.00. Orion Oyj's value of 33.38% is 377.2% above this industry median. Overall, Orion Oyj has a GF Score™ of 100/100, reflecting its overall financial health beyond just this single metric.
How does Orion Oyj's ROCE % compare to LLY and JNJ?
Orion Oyj's ROCE % of 33.38% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.00. Orion Oyj's value of 33.38% is 377.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.00, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Orion Oyj's current ROCE % of 33.38% is 377.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Orion Oyj's current ROCE % is 33.38%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orion Oyj stock overvalued right now?
Orion Oyj (ORINF) has a current ROCE % of 33.38%. The stock's GF Value™ is $86.78, compared to a current price of $82.75 — trading 4.6% below its estimated fair value. The current ROCE % is 33.38% and 377.2% above the Drug Manufacturers industry median of 7.00. Orion Oyj's overall GF Score™ is 100/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Orion Oyj (ORINF), the current ROCE % is 33.38% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Orion Oyj (ORINF) Overvalued in 2026?

Based on GuruFocus' analysis, Orion Oyj stock appears to be undervalued. The current stock price of $82.75 is trading 4.6% below its estimated GF Value™ of $86.78.

Key valuation signals for ORINF:

  • ROCE %: 33.38%
  • GF Value™: $86.78 vs. price of $82.75 (4.6% below fair value)
  • GF Score™: 100/100 with 2 warning signs
  • Industry Position: 377.2% above the Drug Manufacturers median

No single metric tells the full story. See the ORINF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Orion Oyj Business Description

Address Orionintie 1, Espoo, FIN, FI-02200
Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company predominantly focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. The company mainly serves Finland but also has a presence in other European countries, North America and other countries.
100GF Score

Get the complete analysis for ORINF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$82.75
Price
$86.78
GF Value